Saudi Arabia: Tokyo-based Medident has signed an agreement with Saudi Arabia institutions to link Japan’s medical digital transformation strategy with the Kingdom’s Vision 2030 plan.

The pact was inked at the Japan-Saudi EXPO Investment Forum, the company announced on Sept. 24.

The agreement covers areas including artificial intelligence diagnostics, surgical training, medical device development, and healthcare-education platforms.

Medident also plans to speed up clinical and educational adoption of its 3D Clone Model, a training tool that combines virtual reality with tactile simulation based on various types of medical scans.

“Our initiatives are gaining recognition both academically and at the policy level,” Medident CEO Daisuke Tomita said.

“By connecting Japan’s strengths in digital healthcare with Saudi Arabia’s reform agenda, we will build new frameworks for international co-creation.”

The deal was signed on stage at the Saudi-Japan EXPO Investment Forum with Dr. Noor A. Al-Saadoon, director of health innovation at the Biotech Center at Al-Faisal University, and Dr. Mohammed Al-Hayaza, president of Al-Faisal University.

Also in attendance were Khalid A. Al-Falih, minister of investment; KOGA Yuichiro Koga, state minister of economy, trade, and Industry; and Yumiko Tomita, director of the Japan Oral Health Association.